January, 2008

Cureline Newsletter

Biosample Management and Histology Services

January, 2008



Dear Colleague:


During the last three years, Cureline Inc. has significantly expanded its clinical network. Currently our team implements human tissue acquisition projects with clinical sites and alliance partners in Russia, India, the Philippines and the USA.


To address the growing need for high-quality human tissue processing and analysis, Cureline founded in 2007 Cureline BioPathology a research histology laboratory providing services in quality tissue processing and preparation, target profiling, antibody cross-reactivity studies and toxicology.


Both companies recently relocated to a newly renovated building near the San Francisco International airport that contains over 3,000 square feet of administrative space and a state-of the art laboratory facility. For inquiry about our contact us at:


Cureline Inc.
1849 Bayshore Highway, Suite 280
Burlingame, CA 94010
Phone: 650.692.6400
Fax: 650.692.6484
www.cureline.com
www.CurelineBioPathology.com


We look forward to supporting your research programs in 2008!


Sincerely,
Olga Potapova, Ph.D.
Founder, CEO and Scientific Director



Cureline founded in 2007 Cureline BioPathology a research histology laboratory

cureline5 Cureline BioPathology was founded by Cureline to leverage the already established relationships with clinical sites alliance partners and biopharmaceutical community.


Together the companies offer a complete portfolio of services in human tissue research including biospecimen acquisition, storage and comprehensive histology analysis using special stains and immunohistochemical methods.


For detailed information about Cureline BioPathology services and prices, visit www.CurelineBiopathlogy.com.



Learn more about our Histology Services



Oncology Metrics and Cureline Announce Human Tumor Tissues">Joint Marketing Agreement

oncologymetricslogoOncology Metrics, a business that develops products and services to help accelerate advancements in the treatment of cancer and Cureline Inc. have reached an agreement to collaborate on oncology biospecimen procurement and management.


The goal of this collaboration is to facilitate the collection and preservation of high quality pre-treatment and post-treatment samples with maximum efficiency and to provide access to cancer biospecimens collected from diverse ethnic background populations through Cureline's clinical network in Eastern Europe and Asia and through the Oncology Metrics' clinical network in the USA.


Visit our website to learn more about our collaboration.


Learn more about the Oncology Metrics and Cureline Human Tumor Tissues">Joint Marketing Agreement



Learn About Us

 

email: newsletter@cureline.com
phone: (650) 952 6557
web: http://www.cureline.com